The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Data of m6A-seq for YTHDF2 KO SW780 cells and the control.
应用场景：
创建时间：
2023-03-09
相关数据集
N6-methyladenosine (m6A) profiling in 60 YRI LCLs
N6-methyladenosine (m6A), the most abundant messenger RNA (mRNA) modification, has emerged as a critical post-transcriptional mechanism that regulates various aspect of mRNA metabolism including pre-m
NIAID Data Ecosystem70
METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity
Although immunotherapy improves clinical outcomes in several types of malignancies, as an immunologically cold tumor, pancreatic ductal adenocarcinoma is arrantly resistant to immunotherapy. However,
NIAID Data Ecosystem40
Murine MPC5 Cells: Interference_vs_Model
M6A-mRNA&lncRNA Epitranscriptomic Microarray of MPC5 cells comparing HG stimulated cells with HG stimulated cells with METTL3 knockdown. Two-condition experiment, HG-METTL3KD vs. HG cells. Biological
NIAID Data Ecosystem10
RNA-Sequencing of Control KD and KD for Ime4-dMettl14, Fl(2)d, Vir, Nito, CG7358 in S2R+ cells
N6-methyladenosine (m6A) is an abundant RNA modification in eukaryotes, playing crucial roles in multiple biological processes. m6A is catalyzed by the activity of Mettl3, which depends on additional
NIAID Data Ecosystem50
M6A Demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression [MeRIP-seq]. M6A Demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression [MeRIP-seq]
Despite advances in clinical diagnosis and treatment, the prognosis of patients with osteosarcoma (OS) remains poor, and the treatment efficacy has plateaued. Therefore, it is important to identify ne
NIAID Data Ecosystem30
